Ka Kit Wong, MBBS
Clinical Professor of Radiology
Medical Director of Nuclear Medicine Therapy Clinic ACU
Nuclear Medicine and Program Director of Nuclear Medicine Fellowship
Nuclear Medicine Fellowship
[email protected]

Available to mentor
Ka Kit Wong, MBBS
Clinical Professor
  • Research Overview
  • Recent Publications
    • Research Overview

    Pediatric Nuclear Medicine
    Endocrinology Nuclear Medicine
    Hybrid Molecular Imaging (SPECT/CT and PET/CT)
    Theranostics: Nuclear Medicine Therapy
    Novel PET Radiotracers
    Bone Mineral Densitometry
    Meta-Analysis

    Recent Publications See All Publications
    • Journal Article
      Cardiac sympathetic denervation and anxiety in Parkinson disease.
      Carli G, Kanel P, Michalakis F, Roytman S, Bohnen JLB, Wigstrom TP, Scott P, Albin RL, Wong KK, Raffel D, Bohnen NI. Parkinsonism Relat Disord, 2024 Jul; 124: 106997 DOI:10.1016/j.parkreldis.2024.106997
      PMID: 38723520
    • Journal Article
      3-[18F]Fluoro-para-hydroxyphenethylguanidine (3-[18F]pHPG) PET-A Novel Imaging Modality for Paraganglioma.
      Else T, Wong KK, Frey KA, Brooks AF, Viglianti BL, Raffel DM. J Endocr Soc, 2024 Apr 6; 8 (6): bvae049 DOI:10.1210/jendso/bvae049
      PMID: 38617812
    • Journal Article
      Enhancing precision: A predictive model for 177Lu-DOTATATE treatment response in neuroendocrine tumors using quantitative 68Ga-DOTATATE PET and clinicopathological biomarkers.
      Akhavanallaf A, Joshi S, Mohan A, Worden FP, Krauss JC, Zaidi H, Frey K, Suresh K, Dewaraja YK, Wong KK. Theranostics, 2024 14 (9): 3708 - 3718. DOI:10.7150/thno.98053
      PMID: 38948061
    • Journal Article
      SPECT/CT Image-Derived Absorbed Dose to Red Marrow Correlates with Hematologic Toxicity in Patients Treated with [177Lu]Lu-DOTATATE.
      Blakkisrud J, Peterson AB, Wildermann SJ, Kingkiner G, Wong KK, Wang C, Frey KA, Stokke C, Dewaraja YK. J Nucl Med, 2024 May 1; 65 (5): 753 - 760. DOI:10.2967/jnumed.123.266843
      PMID: 38548350
    • Journal Article
      Initial Feasibility and Acute Toxicity Outcomes From a Phase 2 Trial of 18F-Fluorodeoxyglucose Positron Emission Tomography Response-Based De-escalated Definitive Chemoradiotherapy for p16+ Oropharynx Cancer: A Planned Interim Analysis.
      Allen SG, Rosen BS, Aryal M, Cao Y, Schipper MJ, Wong KK, Casper KA, Chinn SB, Malloy KM, Prince ME, Rosko AJ, Shuman AG, Spector ME, Stucken CL, Swiecicki PL, Worden FP, Brenner JC, Schonewolf CA, Elliott DA, Mierzwa ML, Shah JL. Int J Radiat Oncol Biol Phys, 2023 Sep 1; 117 (1): 171 - 180. DOI:10.1016/j.ijrobp.2023.03.043
      PMID: 36931572
    • Journal Article
      Single-Time-Point Imaging for Dosimetry After [177Lu]Lu-DOTATATE: Accuracy of Existing Methods and Novel Data-Driven Models for Reducing Sensitivity to Time-Point Selection.
      Wang C, Peterson AB, Wong KK, Roseland ME, Schipper MJ, Dewaraja YK. J Nucl Med, 2023 Sep; 64 (9): 1463 - 1470. DOI:10.2967/jnumed.122.265338
      PMID: 37500260
    • Journal Article
      The predictive value of pretherapy [68Ga]Ga-DOTA-TATE PET and biomarkers in [177Lu]Lu-PRRT tumor dosimetry.
      Akhavanallaf A, Peterson AB, Fitzpatrick K, Roseland M, Wong KK, El-Naqa I, Zaidi H, Dewaraja YK. Eur J Nucl Med Mol Imaging, 2023 Aug; 50 (10): 2984 - 2996. DOI:10.1007/s00259-023-06252-x
      PMID: 37171633
    • Presentation
      Lu-177 PSMA Radioligand Therapy for Metastatic Prostate Cancer
      Wong KK. 2023 Jul;